Atai Life Sciences N.V.

1.24
-0.12 (-8.82%)
At close: Apr 01, 2025, 3:59 PM
1.26
2.02%
Pre-market: Apr 02, 2025, 07:46 AM EDT

Atai Life Sciences Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
Net Income -150.05M -40.22M -157.42M -174.24M -178.63M -24.38M
Depreciation & Amortization 473K 319K 168K 47K 24K 6K
Stock-Based Compensation 25.49M 32.98M 42.38M 63.36M 67.16M 57K
Other Working Capital -7.33M 5.33M -301K -9.9M 2.75M -375K
Other Non-Cash Items 50.85M -84.66M 8.67M 16.06M 29.88M 9.06M
Deferred Income Tax n/a n/a 5.07M 39.13M 56.35M 7.54M
Change in Working Capital -9.2M 7.47M -3.33M -7.6M 4.45M -126K
Operating Cash Flow -82.44M -84.12M -104.47M -63.25M -20.77M -7.85M
Capital Expenditures n/a -590K -1.02M -1.13M -59K -19K
Acquisitions n/a -443K n/a -52.94M -2.09M -456K
Purchase of Investments n/a -185.26M -309.66M -23.66M -23.92M -11.55M
Sales Maturities Of Investments 83.73M 139.47M 226.83M -955K n/a 10.31M
Other Investing Acitivies -24.56M -6.47M -3M -2.6M -2.2M -7.32M
Investing Cash Flow 59.17M -53.3M -86.85M -81.28M -28.27M -9.03M
Debt Repayment 5M n/a 15M 1.59M 32.5M n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 374K -8.36M 5.18M 2.42M -1.89M -2.29M
Financial Cash Flow 5.37M -8.36M 20.79M 409.86M 113.05M 40.39M
Net Cash Flow -17.53M -145.58M -171.65M 265.02M 67.18M 23.14M
Free Cash Flow -82.44M -84.71M -105.49M -64.37M -20.82M -7.87M